Skip to main content
Yea-Yuan Chang on Muck Rack

Yea-Yuan Chang

Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Yea-Yuan

Contact Yea-Yuan, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Comparison of Cefepime-Cefpirome and Carbapenem Therapy for Acinetobacter Bloodstream Infection in a Multicenter Study

|
By Yea-Yuan Chang, Ya-Sung Yang, Yung-Chih Wang, Shang-Liang Wu
| American Society for Microbiology (ASM)
Clinical Therapeutics Yea-Yuan Chang, Ya-Sung Yang, Shang-Liang Wu, Yung-Chih Wang, Te-Li Chen; on behalf of the ACTION Study Group, Yi-Tzu Lee DOI: 10.1128/AAC.02392-19 ABSTRACT Carbapenems are currently the preferred agents for the treatment of serious Acinetobacter infections. However, whether cefepime-cefpirome can be used to treat an Acinetobacter bloodstream infection (BSI) if it is active against the causative pathogen(s) is not clear.
Open in Who Shared Issue with article?

Influenza vaccination and secondary prevention of cardiovascular disease among Taiwanese elders-A propensity score-matched follow-up study

|
By Hao-Hsin Wu, Yea-Yuan Chang, Shu-Chen Kuo, Yung-Tai Chen
| PLOS
Loading metrics Open Access Peer-reviewed Research Article Hao-Hsin Wu, Yea-Yuan Chang, Shu-Chen Kuo , Yung-Tai Chen Hao-Hsin Wu, Yea-Yuan Chang, Shu-Chen Kuo, Yung-Tai Chen Published: July 1, 2019 https://doi.org/10.1371/journal.pone.0219172 Figures Abstract The present study aimed to evaluate the association between influenza vaccination and the secondary prevention of cardiovascular disease (CVD) among elderly persons.
Open in Who Shared Issue with article?

Use of lipid-lowering agents is not associated with improved outcomes for tuberculosis patients on standard-course therapy: A population-based cohort study

|
By Yung-Tai Chen, Shu-Chen Kuo, Pei-Wen Chao, Yea-Yuan Chang
| PLOS
Loading metrics Open Access Peer-reviewed Research Article Yung-Tai Chen, Shu-Chen Kuo, Pei-Wen Chao, Yea-Yuan Chang Yung-Tai Chen, Shu-Chen Kuo, Pei-Wen Chao, Yea-Yuan Chang Published: January 11, 2019 https://doi.org/10.1371/journal.pone.0210479 Figures Abstract Objectives Animal and ex vitro studies suggested lipid-lowering agents (LLAs) may be used as an adjunct to standard anti- tuberculosis (TB) treatment. No human study has been conducted to date.
Open in Who Shared Issue with article?
See all 3 articles